Xanodyne Pharmaceuticals Inc. which makes Darvon and Darvocet, the brand version of the prescription pain medication propoxyphene, has agreed to withdraw the medication from the U.S. market at the request of the FDA. The FDA has also informed the generic manufacturers of propoxyphene-containing products of Xanodyne’s decision and requested that they voluntarily remove their products as well.  A replay of the call will be available until December 3 by calling 888-277-5071, or for international callers, 402-998-0496.     http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm234350.htm